Mark Glickman

Mark A. Glickman is President & Chief Executive Officer at BioFlorida, Inc. since 2023.
He is Director at Otsuka Precision Health, Inc. starting in 2024.
He serves as Independent Director at MetaVia, Inc. since 2023 and at BioStem Technologies, Inc. beginning in 2026.
Formerly, Mr. Glickman was Co-CEO & Chief Business Officer at TherapeuticsMD, Inc. from 2022 to 2023.
He was Marketing Director & Vice President-Sales at KOS Pharmaceuticals, Inc. from 2001 to 2007.
He held the position of General Manager-Sales at Baxter Healthcare Corp.
from 1989 to 1995.
He served as Senior Vice President-Sales & Marketing at Oscient Pharmaceuticals Corp.
from 2007 to 2009.
He was Chief Commercial Officer at Esperion Therapeutics, Inc. from 2018 to 2020.
He held the role of Chief Commercial Officer at POZEN, Inc. from 2015 to 2016.
He was Senior Vice President-Sales at Auxilium Pharmaceuticals LLC from 2012 to 2015.
He was Vice President-Sales at Bayer HealthCare.
He served as Vice President-Medical Device Division at Otsuka America Pharmaceutical, Inc. from 2009 to 2012.
He was Chief Commercial Officer at Old API Wind-down Ltd. from 2015 to 2018.
Education includes undergraduate studies at State University of New York College at Oswego and an MBA from NYU Stern School of Business.